VVM
Versant Venture Management Portfolio holdings
AUM
$151M
1-Year Est. Return
77.88%
This Fund
S&P 500
1 Year Est. Return
+77.88%
AUM
$151M
AUM Growth
-$61.4M
(-29%)
Holding
9
Top Buys
No buys this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Monte Rosa Therapeutics
GLUE
$1.25B
| $68.7M | 45.49% |
4,382,687
-1,270,235
|
|
||
|
LENZ
2
LENZ Therapeutics
LENZ
$328M
| $42.5M | 28.14% |
2,656,888
|
|
||
|
JBIO
3
Jade Biosciences
JBIO
$690M
| $23.5M | 15.59% |
1,525,820
|
|
||
4
CRISPR Therapeutics
CRSP
$4.44B
| $7.8M | 5.17% |
148,831
|
|
||
|
CTNM
5
Contineum Therapeutics
CTNM
$456M
| $6.2M | 4.11% |
542,628
|
|
||
6
Skye Bioscience
SKYE
$20.8M
| $1.51M | 1% |
2,007,704
|
|
||
7
Tempest Therapeutics
TPST
$30.9M
| $774K | 0.51% |
269,772
|
|
||
|
ADVM
8
DELISTED
Adverum Biotechnologies
ADVM
| – | – |
-506,821
|
|
||
|
RPTX
9
DELISTED
Repare Therapeutics
RPTX
| – | – |
-2,646,657
|
|